Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Oncology·MeSH: Lymphoma, Non-Hodgkin
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell?
There are 1 clinical trial targeting Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell tracked by BioSniper.
What is the prevalence of Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell?
The estimated prevalence of Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell is approximately 56.0 per 100,000 population.
Deep-dive into Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis